Dolores R. Serrano - Search Results

Year	Number of Results
2013	2
2014	2
2015	4
2016	3
2017	10
2018	10
2019	7
2020	9
2021	6
2022	4

1

Antifungal and Antiparasitic Drug Delivery.

Torrado JJ, Serrano DR, Capilla J. Torrado JJ, et al. Among authors: serrano dr. Pharmaceutics. 2020 Apr 4;12(4):324. doi: 10.3390/pharmaceutics12040324. Pharmaceutics. 2020. PMID: 32260348 Free PMC article.

2

Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Romero A, Ramos E, López-Muñoz F, De Los Ríos C, Egea J, Gil-Martín E, Pita R, Torrado JJ, Serrano DR, Juberias A. Romero A, et al. Among authors: serrano dr. Diseases. 2021 Apr 10;9(2):27. doi: 10.3390/diseases9020027. Diseases. 2021. PMID: 33920224 Free PMC article. Review.

3

Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis.

Bezerra-Souza A, Jesus JA, Laurenti MD, Lalatsa A, Serrano DR, Passero LFD. Bezerra-Souza A, et al. Among authors: serrano dr. J Immunol Res. 2021 Mar 31;2021:8828750. doi: 10.1155/2021/8828750. eCollection 2021. J Immunol Res. 2021. PMID: 33880383 Free PMC article.

4

Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines.

Kara A, Vassiliadou A, Ongoren B, Keeble W, Hing R, Lalatsa A, Serrano DR. Kara A, et al. Among authors: serrano dr. Pharmaceutics. 2021 Dec 10;13(12):2134. doi: 10.3390/pharmaceutics13122134. Pharmaceutics. 2021. PMID: 34959415 Free PMC article.

5

Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.

Lalatsa A, Statts L, Adriana de Jesus J, Adewusi O, Auxiliadora Dea-Ayuela M, Bolas-Fernandez F, Dalastra Laurenti M, Felipe Domingues Passero L, Serrano DR. Lalatsa A, et al. Among authors: serrano dr. Int J Pharm. 2020 Oct 15;588:119734. doi: 10.1016/j.ijpharm.2020.119734. Epub 2020 Aug 7. Int J Pharm. 2020. PMID: 32777535

6

Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous Nanomaterials.

Serrano DR, Gallagher KH, Healy AM. Serrano DR, et al. Curr Top Med Chem. 2015;15(22):2327-40. doi: 10.2174/1568026615666150605122917. Curr Top Med Chem. 2015. PMID: 26043733 Review.

7

Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing.

Fernández-García R, Prada M, Bolás-Fernández F, Ballesteros MP, Serrano DR. Fernández-García R, et al. Among authors: serrano dr. Pharm Res. 2020 Jun 17;37(7):132. doi: 10.1007/s11095-020-02847-3. Pharm Res. 2020. PMID: 32556831 Review.

8

New Drugs and Therapeutic/Diagnostic Targets for Fungal and Parasitic Diseases - Part I.

Dea-Ayuela MA, Serrano DR. Dea-Ayuela MA, et al. Among authors: serrano dr. Curr Top Med Chem. 2018;18(15):1274. doi: 10.2174/156802661815181101110430. Curr Top Med Chem. 2018. PMID: 30598060

9

New Drugs and Therapeutic/Diagnostic Targets for Fungal and Parasitic Diseases - Part II.

Dea-Ayuela MA, Serrano DR. Dea-Ayuela MA, et al. Among authors: serrano dr. Curr Top Med Chem. 2018;18(16):1357. doi: 10.2174/156802661816181107142130. Curr Top Med Chem. 2018. PMID: 30497354

10

Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?

Konta AA, García-Piña M, Serrano DR. Konta AA, et al. Among authors: serrano dr. Bioengineering (Basel). 2017 Sep 22;4(4):79. doi: 10.3390/bioengineering4040079. Bioengineering (Basel). 2017. PMID: 28952558 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results